NCT00182988
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
Clinical trial condition
Alzheimer's Disease
Explore clinical trials studying Alzheimer's Disease. Study availability and eligibility vary by location and protocol.
815 public trials
50 recruiting studies
Alzheimer's Disease trial results
NCT00931073
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
- Locations
-
- Pfizer Investigational Site Kalamazoo, Michigan, United States
NCT00838877
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Research Site Huddinge, Sweden
- Research Site Stockholm, Sweden
Completed
A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
NCT00455000
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Pfizer Investigational Site Heidelberg West, Victoria, Australia
- Pfizer Investigational Site Fremantle, Western Australia, Australia
- Pfizer Investigational Site Nedlands, Western Australia, Australia
- Pfizer Investigational Site London, Ontario, Canada
Completed
Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers
NCT00329082
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Haven, Connecticut, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington D.C., District of Columbia, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States
NCT00880412
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Hôpital Privé Les Magnolias Ballainvilliers, France
- Cabinet Médical Bergerac, France
- Fleyriat Hospital Bourg-en-Bresse, France
- Cabinet Médical Dijon, France
NCT00979446
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Behavior, +12 more
- Locations
-
- HealthPartners Research Foundation Bloomington, Minnesota, United States
NCT00151333
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Phoenix, Arizona, United States
- Fort Lauderdale, Florida, United States
- Miami, Florida, United States
NCT00130429
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Oxford Project to Investigate Memory and Ageing Oxford, Oxfordshire, United Kingdom
Completed
Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease
NCT00733642
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Pfizer Investigational Site Glendale, California, United States
- Pfizer Investigational Site Eatontown, New Jersey, United States
- Pfizer Investigational Site Oakhurst, New Jersey, United States